People with type 2 diabetes experienced worsening of glycaemic values during lockdown, review finds
Research into the effect of lockdown on people with diabetes has found that while those with type 1 saw “significant” improvements in glycaemic values, those with type 2 were adversely affected.
Researchers from Hochschule Fulda-University of Applied Sciences in Germany looked at a number of studies to review the impact of the COVID-19 lockdown on glycaemic control in people with diabetes.
They examined studies involving 2,881 people with type 1 diabetes and 1,823 people with type 2 diabetes.
For those with type 1, they found that 72 per cent of the studies indicated significant improvements in glycaemic outcomes, while for type 2 diabetes, 50 per cent of the publications observed deteriorations in glycaemic control.
The researchers, who used databases including Cochrane Library, MEDLINE via PubMed and Web of Science Core Collection, said: “Glycaemic values in people with T1D significantly improved during COVID-19 lockdown, which may be associated with positive changes in self-care and digital diabetes management. In contrast, lockdown rather determined a short-term worsening in glycaemic parameters in patients with T2D.
“Further research is required, particularly into the causes and effective T2D management during lockdown.”